Vicore Pharma Holding AB (publ)
SSE:VICO.ST
14.38 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Vicore Pharma Holding AB (publ) |
Symbool | VICO.ST |
Munteenheid | SEK |
Prijs | 14.38 |
Beurswaarde | 1,606,576,740 |
Dividendpercentage | 0% |
52-weken bereik | 12.36 - 26.9 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ahmed S. Mousa J.D. |
Website | https://www.vicorepharma.com |
An error occurred while fetching data.
Over Vicore Pharma Holding AB (publ)
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)